Skip to main content

Advertisement

Log in

Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course

  • Original Article—Liver, Pancreas, and Biliary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Autoimmune pancreatitis (AIP) has the potential to progress to a chronic state that forms pancreatic stones. The aim of this study was to clarify the risk factors underlying pancreatic stone formation in AIP.

Methods

Sixty-nine patients with AIP who had been followed for at least 3 years were enrolled for evaluation of clinical and laboratory factors as well as computed tomography and endoscopic retrograde cholangiopancreatography findings.

Results

During the course of this study, increased or de novo stone formation was seen in 28 patients, who were defined as the stone-forming group. No stones were observed in 32 patients, who were defined as the non-stone-forming group. Nine patients who had stones at diagnosis but showed no change during the course of this study were excluded from our cohort. Univariate analysis revealed no significant differences in clinical or laboratory factors associated with AIP-specific inflammation between the two groups. However, pancreatic head swelling (P = 0.006) and narrowing of both Wirsung’s and Santorini’s ducts in the pancreatic head region (P = 0.010) were significantly more frequent in the stone-forming group. Furthermore, multivariate analysis identified Wirsung and Santorini duct narrowing at diagnosis as a significant independent risk factor for pancreatic stone formation (OR 4.4, P = 0.019).

Conclusions

A primary risk factor for pancreatic stone formation in AIP was narrowing of both Wirsung’s and Santorini’s ducts, which most presumably led to pancreatic juice stasis and stone development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

AIP:

Autoimmune pancreatitis

CT:

Computed tomography

ERCP:

Endoscopic retrograde cholangiopancreatography

References

  1. Kawa S, Hamano H, Kiyosawa K. The autoimmune diseases. In: Rose N, MacKay I, editors. Pancreatitis. 4th ed. St Louis: Academic; 2006.

  2. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.

    Article  PubMed  CAS  Google Scholar 

  3. Hamano H, Kawa S, Ochi Y, Unno H, Shiba N, Wajiki M, et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet. 2002;359:1403–4.

    Article  PubMed  Google Scholar 

  4. Yoshida K, Toki F, Takeuchi T, Watanabe S, Shiratori K, Hayashi N. Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci. 1995;40:1561–8.

    Article  PubMed  CAS  Google Scholar 

  5. Takayama M, Hamano H, Ochi Y, Saegusa H, Komatsu K, Muraki T, et al. Recurrent attacks of autoimmune pancreatitis result in pancreatic stone formation. Am J Gastroenterol. 2004;99:932–7.

    Article  PubMed  Google Scholar 

  6. Kawa S, Hamano H, Ozaki Y, Ito T, Kodama R, Chou Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol. 2009;7:S18–22.

    Article  PubMed  CAS  Google Scholar 

  7. Takuma K, Kamisawa T, Tabata T, Inaba Y, Egawa N, Igarashi Y. Short-term and long-term outcomes of autoimmune pancreatitis. Eur J Gastroenterol Hepatol. 2011;23:146–52.

    Article  PubMed  CAS  Google Scholar 

  8. Suzuki K, Itoh S, Nagasaka T, Ogawa H, Ota T, Naganawa S. CT findings in autoimmune pancreatitis: assessment using multiphase contrast-enhanced multisection CT. Clin Radiol. 2010;65:735–43.

    Article  PubMed  CAS  Google Scholar 

  9. Sah RP, Pannala R, Chari ST, Sugumar A, Clain JE, Levy MJ, et al. Prevalence, diagnosis, and profile of autoimmune pancreatitis presenting with features of acute or chronic pancreatitis. Clin Gastroenterol Hepatol. 2010;8:91–6.

    Article  PubMed  Google Scholar 

  10. Takada H, Nakazawa T, Ohara H, Ando T, Hayashi K, Naito I, et al. Role of osteopontin in calcification in autoimmune pancreatitis. Dig Dis Sci. 2009;54:793–801.

    Article  PubMed  CAS  Google Scholar 

  11. Nakazawa T, Ohara H, Sano H, Ando T, Imai H, Takada H, et al. Difficulty in diagnosing autoimmune pancreatitis by imaging findings. Gastrointest Endosc. 2007;65:99–108.

    Article  PubMed  Google Scholar 

  12. Nishino T, Toki F, Oyama H, Shimizu K, Shiratori K. Long-term outcome of autoimmune pancreatitis after oral prednisolone therapy. Intern Med. 2006;45:497–501.

    Article  PubMed  Google Scholar 

  13. Takayama T. Pathophysiological study of experimental pancreatolithiasis in the dog. Jpn J Gastroenterol. 1979;76:1325–36. (in Japanese with English abstract).

    CAS  Google Scholar 

  14. Konishi K, Izumi R, Kato O, Yamaguchi A, Miyazaki I. Experimental pancreatolithiasis in the dog. Surgery. 1981;89:687–91.

    PubMed  CAS  Google Scholar 

  15. Wakabayashi T, Kawaura Y, Satomura Y, Watanabe H, Motoo Y, Sawabu N. Long-term prognosis of duct-narrowing chronic pancreatitis: strategy for steroid treatment. Pancreas. 2005;30:31–9.

    PubMed  CAS  Google Scholar 

  16. Horiuchi A, Kawa S, Hamano H, Hayama M, Ota H, Kiyosawa K. ERCP features in 27 patients with autoimmune pancreatitis. Gastrointest Endosc. 2002;55:494–9.

    PubMed  Google Scholar 

  17. Otsuki M, Chung JB, Okazaki K, Kim MH, Kamisawa T, Kawa S, et al. Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan–Korea symposium on autoimmune pancreatitis. J Gastroenterol. 2008;43:403–8.

    Article  PubMed  CAS  Google Scholar 

  18. Haaga JR, Alfidi RJ, Zelch MG, Meany TF, Boller M, Gonzalez L, et al. Computed tomography of the pancreas. Radiology. 1976;120:589–95.

    PubMed  CAS  Google Scholar 

  19. Muraki T, Hamano H, Ochi Y, Komatsu K, Komiyama Y, Arakura N, et al. Autoimmune pancreatitis and complement activation system. Pancreas. 2006;32:16–21.

    Article  PubMed  Google Scholar 

  20. Kawa S, Hamano H, Kiyosawa K. High serum IgG4 concentrations in patients with sclerosing pancreatitis. Reply. N Engl J Med. 2001;345:147–8.

    Google Scholar 

  21. Song MH, Kim MH, Lee SK, Seo DW, Lee SS, Han J, et al. Regression of pancreatic fibrosis after steroid therapy in patients with autoimmune chronic pancreatitis. Pancreas. 2005;30:83–6.

    Article  PubMed  Google Scholar 

  22. Ko SB, Mizuno N, Yatabe Y, Yoshikawa T, Ishiguro H, Yamamoto A, et al. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis. Gastroenterology. 2010;138:1988–96.

    Article  PubMed  CAS  Google Scholar 

  23. Stevens T, Conwell DL, Zuccaro G. Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments. Am J Gastroenterol. 2004;99:2256–70.

    Article  PubMed  CAS  Google Scholar 

  24. Braganza JM, Lee SH, McCloy RF, McMahon MJ. Chronic pancreatitis. Lancet. 2011;377:1184–97.

    Article  PubMed  CAS  Google Scholar 

  25. Sarles H. Etiopathogenesis and definition of chronic pancreatitis. Dig Dis Sci. 1986;31:91S–107S.

    Article  PubMed  CAS  Google Scholar 

  26. Suda K, Takase M, Takei K, Kumasaka T, Suzuki F. Histopathologic and immunohistochemical studies on the mechanism of interlobular fibrosis of the pancreas. Arch Pathol Lab Med. 2000;124:1302–5.

    PubMed  CAS  Google Scholar 

  27. Origuchi N, Kimura W, Muto T, Esaki Y. Pancreatic mucin-producing adenocarcinoma associated with a pancreatic stone: report of a case. Surg Today. 1998;28:1261–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported partially by the Research Program of Intractable Disease provided by the Ministry of Health, Labor, and Welfare of Japan, and in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports, and Culture of Japan (23591012). We thank Trevor Ralph for his English editorial assistance.

Conflict of interest

None of the authors have any conflicts of interest associated with this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shigeyuki Kawa.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maruyama, M., Arakura, N., Ozaki, Y. et al. Risk factors for pancreatic stone formation in autoimmune pancreatitis over a long-term course. J Gastroenterol 47, 553–560 (2012). https://doi.org/10.1007/s00535-011-0510-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-011-0510-y

Keywords

Navigation